TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35120040 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 35120040 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 33012264 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 32099001 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32423512 — Surrogate Endpoint (SUR): Blood pressure
Study 34130581 — Predictive Biomarker (PRD): WWTR1 mRNA
Genes: WWTR1; TAZ
Study 35714174 — Surrogate Endpoint (SUR): Blood pressure
Study 36209091 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35927637 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 35927637 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34527611 — Surrogate Endpoint (SUR): Bone mineral density
Study 34919247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34919247 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 33838673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33838673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35639660 — Predictive Biomarker (PRD): DSE mRNA
Genes: DSE; SART2
Study 36364735 — Surrogate Endpoint (SUR): Probing pocket depth
Study 33177477 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34625826 — Surrogate Endpoint (SUR): Bone mineral density
Study 34242497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34487062 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 34535047 — Surrogate Endpoint (SUR): Blood pressure
Study 36231510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33820931 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32916413 — Predictive Biomarker (PRD): TMEM11 mRNA
Genes: TMEM11; C17orf35; PM1
Study 32916413 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34218987 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34218987 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34218987 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 34236130 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34518310 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study 33227548 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 34286472 — Surrogate Endpoint (SUR): Blood pressure
Study 32407179 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32407179 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study 32407179 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 32152930 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 33677928 — Surrogate Endpoint (SUR): Bone mineral density
Study 33039717 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 33671166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33671166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33671166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33671166 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 33671166 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 32852460 — Surrogate Endpoint (SUR): Blood pressure
Study 32852460 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32620163 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32620163 — Predictive Biomarker (PRD): Hormone receptor
Study 32272659 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 35099991 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 35427495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33118677 — Predictive Biomarker (PRD): GPR180 mRNA
Genes: GPR180; ITR
Study 33106968 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 36122439 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33504865 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 32087417 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 32087417 — Predictive Biomarker (PRD): ADCY9 mRNA
Genes: ADCY9; KIAA0520
Study 32087417 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36100893 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 33162795 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 32785233 — Surrogate Endpoint (SUR): Blood pressure
Study 32785233 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32785233 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35861823 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34096413 — Surrogate Endpoint (SUR): Blood pressure
Study 35938345 — Surrogate Endpoint (SUR): Blood pressure
Study 33512910 — Surrogate Endpoint (SUR): Serum testosterone
Study 34615722 — Predictive Biomarker (PRD): INPP4B mRNA
Genes: INPP4B
Study 34425156 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34335043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34108518 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34108518 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DMRT1 mRNA
Genes: DMRT1; DMT1
Study 34474622 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34849659 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 36072410 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36072410 — Surrogate Endpoint (SUR): Serum uric acid
Study 32282572 — Predictive Biomarker (PRD): ASPSCR1 mRNA
Genes: ASPSCR1; ASPL; RCC17; TUG; UBXD9; UBXN9
Study 34700609 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study 34700609 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 34700609 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 35354614 — Predictive Biomarker (PRD): DGAT2 mRNA
Genes: DGAT2; HMFN1045; UNQ738/PRO1433
Study 32360852 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33893561 — Surrogate Endpoint (SUR): Serum sodium
Study 35134631 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35134631 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 35134631 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 35312562 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34794330 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study 34794330 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 36057768 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study 32223104 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 32223104 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 32370802 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study 35636621 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 35636621 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33970700 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study 36125447 — Surrogate Endpoint (SUR): Blood pressure
Study 36125447 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36125447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36125447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36125447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33484821 — Predictive Biomarker (PRD): SLC40A1 mRNA
Genes: SLC40A1; FPN; FPN1; IREG1; SLC11A3; MSTP079
Study 36473763 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36473763 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34616836 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 33012654 — Predictive Biomarker (PRD): NAT8 mRNA
Genes: NAT8; CML1; GLA; TSC501
Study 33909554 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 34061178 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34061178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36496349 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 35622972 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 35622972 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 36344987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 36344987 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 36344987 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 33377242 — Safety Biomarker (SAF): MTHFR
Study 34433897 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33040826 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33532995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33532995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33532995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34945073 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 36401407 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 36401407 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 36401407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 35467095 — Surrogate Endpoint (SUR): Serum testosterone
Study 32036964 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32036964 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 32036964 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study 32036964 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study 32036964 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 32036964 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35659763 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 35659763 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 35241426 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 33879820 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 34921201 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 36438688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35749413 — Surrogate Endpoint (SUR): Blood pressure
Study 33677694 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 32106075 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 35961948 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35961948 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 36483239 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 33516240 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34823467 — Surrogate Endpoint (SUR): Blood pressure
Study 34250817 — Surrogate Endpoint (SUR): Blood pressure
Study 34330756 — Surrogate Endpoint (SUR): Blood pressure
Study 36141823 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 36141823 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36141823 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33812910 — Surrogate Endpoint (SUR): Serum sodium
Study 34654643 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34431970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33739848 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33739848 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33053258 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study 33262578 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32106619 — Predictive Biomarker (PRD): HES1 mRNA
Genes: HES1; BHLHB39; HL; HRY
Study 32106619 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 32106619 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 32106619 — Predictive Biomarker (PRD): JAG1 mRNA
Genes: JAG1; JAGL1
Study 32106619 — Predictive Biomarker (PRD): DLL4 mRNA
Genes: DLL4; UNQ1895/PRO4341
Study 32106619 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36153475 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 36153475 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 32199095 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 33007527 — Surrogate Endpoint (SUR): Bone mineral density
Study 32203065 — Surrogate Endpoint (SUR): Blood pressure
Study 34981693 — Surrogate Endpoint (SUR): Blood pressure
Study 33279854 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 33170731 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study 33170731 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 33285743 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34514815 — Surrogate Endpoint (SUR): Blood pressure
Study 35859388 — Safety Biomarker (SAF): Human leucocyte antigen
Study 32894760 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study 32390113 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 32390113 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34818873 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 34481910 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 34481910 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34613954 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 33225965 — Safety Biomarker (SAF): Interleukin 1
Study 32552685 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 34217236 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 32469398 — Surrogate Endpoint (SUR): Blood pressure
Study 33296798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32150215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35075385 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35075385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35075385 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33421538 — Surrogate Endpoint (SUR): Bone mineral density
Study 34612617 — Surrogate Endpoint (SUR): Blood pressure
Study 34612617 — Surrogate Endpoint (SUR): Serum sodium
Study 32464957 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study 32464957 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 32464957 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study 32464957 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study 32464957 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 33331082 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33412120 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34091874 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34960030 — Predictive Biomarker (PRD): PXN mRNA
Genes: PXN
Study 35115348 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 34037889 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 32098895 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 33306939 — Surrogate Endpoint (SUR): Blood pressure
Study 36104785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36104785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36104785 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36104785 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 36104785 — Safety Biomarker (SAF): IL-6 and IL-10
Study 33403886 — Surrogate Endpoint (SUR): Blood pressure
Study 32805626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35932953 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35721734 — Surrogate Endpoint (SUR): Blood pressure
Study 34256668 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35879941 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33752636 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 616671307 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 33409919 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35444528 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 35635335 — Safety Biomarker (SAF): Hyaluronic acid
Study 32393728 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36041869 — Surrogate Endpoint (SUR): Blood pressure
Study 34251903 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34465368 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 32967912 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 32967912 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 32951538 — Surrogate Endpoint (SUR): Blood pressure
Study 32951538 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33405051 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33405051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study 33405051 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 33405051 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 36429402 — Surrogate Endpoint (SUR): Blood pressure
Study 33305643 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 33305643 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 36171282 — Surrogate Endpoint (SUR): Blood pressure
Study 32151220 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 33069172 — Surrogate Endpoint (SUR): Blood pressure
Study 33386756 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 35568049 — Surrogate Endpoint (SUR): Blood pressure
Study 32700421 — Surrogate Endpoint (SUR): Blood pressure
Study 33542371 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study 33292982 — Surrogate Endpoint (SUR): Blood pressure
Study 33452595 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 34922061 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 34922061 — Safety Biomarker (SAF): Interleukin 1
Study 36469833 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33481813 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33931884 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 32381158 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32381158 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32282021 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 35141806 — Surrogate Endpoint (SUR): Probing pocket depth
Study 32228267 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33022991 — Predictive Biomarker (PRD): FFAR2 mRNA
Genes: FFAR2; FFA2; GPCR43; GPR43
Study 34972191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): GZMB mRNA
Genes: GZMB; CGL1; CSPB; CTLA1; GRB
Study 33600826 — Predictive Biomarker (PRD): MZB1 mRNA
Genes: MZB1; MEDA7; PACAP; HSPC190
Study 32240892 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 33745962 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35354637 — Surrogate Endpoint (SUR): Blood pressure
Study 32749942 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32749942 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35883115 — Surrogate Endpoint (SUR): Blood pressure
Study 33976543 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33022197 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33810414 — Surrogate Endpoint (SUR): Blood pressure